{
  "docId": "019dd923-5ca1-7489-b633-671619672db6",
  "docSlug": "be7f58e911596f6c",
  "documentTitle": "Strategy at the Pace of Technology",
  "authorId": "Accenture",
  "authorName": "Accenture",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 9,
  "pageCount": 28,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide highlights Moderna as a 'digital biotech' pioneer and notes the industry-wide shift toward AI-driven drug discovery.",
  "elementsJson": [
    "paragraph",
    "photo"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b633-671619672db6/9",
  "deckHref": "/decks/019dd923-5ca1-7489-b633-671619672db6",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b633-671619672db6.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b633-671619672db6#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "It is now using similar techniques to develop other mRNA-based therapeutics, targeting treatments for rare diseases. Even the more reluctant big pharma players have now started to infuse AI into their drug discovery to catch up with AI-native biotechs such as Moderna.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-9f68-71f9-9a8d-d142e91e5ced",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.769,
        "w": 0.348,
        "x": 0.158,
        "y": 0
      },
      "kind": "image",
      "text": "Scientist in a lab setting",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7372fa4-bbae-496c-8474-dfb7204a212e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "COVID-19 vaccine development time: 1 year (vs. typical 5-10 years)",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-9f68-71f9-9a8d-da8418b75f2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.546,
        "y": 0.158
      },
      "kind": "paragraph",
      "text": "In life sciences, Moderna became a household name in the US and beyond when it developed its COVID-19 vaccine in just one year (versus the typical 5-10 years needed). Its unique business strategy led to incredible success by combining scientific advances with modern data/AI to develop digitally programable mRNA. By mimicking biology, therapeutics can hack the body into creating proteins that stop or reverse illness. Not only is this innovative, it’s also faster and more repeatable than creating individual drugs that combat specific diseases. From the start, CEO Stéphane Bancel wanted Moderna to become the “first truly digital biotech company.”4",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c7b5ad9-66a6-4576-94c0-6ca097baa781",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.546,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "It is now using similar techniques to develop other mRNA-based therapeutics, targeting treatments for rare diseases. Even the more reluctant big pharma players have now started to infuse AI into their drug discovery to catch up with AI-native biotechs such as Moderna.5",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c830284-e10a-471b-a89b-7f455be56ae4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"first truly digital biotech company.\" — CEO Stéphane Bancel",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd951-9f68-71f9-9a8d-d4cba5ba0107",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "COVID-19 vaccine development time",
      "numberRaw": "1 year (vs. typical 5-10 years)",
      "numberKind": "plain",
      "actionTitle": "In life sciences, Moderna became a household name in the US and beyond when it developed its COVID-19 vaccine in just one year (versus the typical 5-10 years needed).",
      "calloutText": "It is now using similar techniques to develop other mRNA-based therapeutics, targeting treatments for rare diseases. Even the more reluctant big pharma players have now started to infuse AI into their drug discovery to catch up with AI-native biotechs such as Moderna.",
      "numberScale": null,
      "numberValue": 1,
      "metricFamily": "other",
      "numberCurrency": null
    }
  ],
  "tools": [
    {
      "name": "Concrete Language",
      "slug": "concrete-language",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019dd95a-0e8a-77b7-b1fc-e4a00bb9258b",
      "evidence": "Specific contrast: 1 year vs typical 5-10 years for vaccine development.",
      "confidence": 80
    },
    {
      "name": "Contrast Pairs",
      "slug": "contrast-pairs",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019dd95a-0e8a-77b7-b1fc-e919208b6ee3",
      "evidence": "1 year vs 5-10 years frames the magnitude of the change.",
      "confidence": 75
    },
    {
      "name": "Sinatra Test",
      "slug": "sinatra-test",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019dd95a-0e8a-77b7-b1fc-e0910d3779a6",
      "evidence": "Moderna's COVID vaccine in 1 year — flagship example of tech-enabled speed.",
      "confidence": 80
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 8,
      "beatId": "019dd95a-0682-776c-8e31-876d93e0e75c",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "JPMorgan/Moderna cases + 'just 21% of companies fully leveraging technology'.",
      "position": 2,
      "confidence": 72,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 13,
      "from": 4,
      "beatId": "019dd95a-0682-776c-8e31-94d7135fdca7",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Establishes tech-forward gap and outperformance data.",
      "position": 1,
      "confidence": 55,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 8,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d39-780c06ce5135",
      "evidence": "JPMorgan in finance (p8) + Moderna in life sciences (p9) jointly point to the 'speed' pattern.",
      "position": 2,
      "objective": "Stack cross-industry cases to prove tech-driven disruption is rapid",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 78,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}